Home | Knowledge Center | Somnia Blog

Somnia Blog

MON, MAR 31, 2014

FDA "Safe Use" Initiative Under Fire

Are FDA safety initiatives always sufficient? According to Somnia’s own Clifford Gevirtz, MD, the answer is an easy ‘NO’. According to the FDA website, “The goal of the Safe Use Initiative is to reduce preventable harm by identifying specific, preventable medication risks…” A Bronx-based anesthesiologist, Dr. Clifford Gevirtz, unwaveringly called-out the FDA, claiming... Read More

FRI, MAR 21, 2014

Record CEO Turnover Rates Brings New Challenges to US Hospitals

By: Hugh Morgan, VP Quality Management, Somnia Anesthesia   Hospital CEO turnover rates have reached record highs, and there are no signs of slowing down in the near future. This is just one of the many challenges that has emerged with the ever-changing healthcare landscape, and is becoming a real concern amongst... Read More

WED, FEB 26, 2014

Still Possible for ASCs to Succeed in Light of Restrictive Policies and Programs

Ambulatory Surgery Centers (ASCs) seemingly never get a break when it comes to reimbursement and Medicare payment policies, especially during the last decade. According to Becker’s ASC Review, the Medicare Payment Advisory Commission (MedPAC) has continued to decrease the overall reimbursement payments towards ASCs since 2003. Usually a percentage of... Read More

WED, FEB 5, 2014

Quality Pain Management: What is it Exactly?

While reading through various anesthesia articles this week, I came across an abstract of a study that was conducted by Sigridur Zoëga MS, RN, CNS and company earlier this month. The purpose of the study was to “explore the concept of quality pain management (QPM) in adult hospitalized patients.” According to Zoëga,... Read More

FRI, JAN 24, 2014

ASA Releases Recommendations for Commercial Use of Sedasys

As a follow-up to our previous blog post, “2014: The Year of the Robot Anesthesiologist,” it is only fitting that we discuss the American Society of Anesthesiologists’ (ASA) guidelines and recommendations that it released Wednesday (Jan. 22, 2014) for Johnson and Johnson’s computer-assisted personalized-sedation (CAPS) system, Sedasys. Beginning this year, Sedasys... Read More